318 related articles for article (PubMed ID: 27442440)
1. Adherence to Concurrent Tuberculosis Treatment and Antiretroviral Treatment among Co-Infected Persons in South Africa, 2008-2010.
Webb Mazinyo E; Kim L; Masuku S; Lancaster JL; Odendaal R; Uys M; Podewils LJ; Van der Walt ML
PLoS One; 2016; 11(7):e0159317. PubMed ID: 27442440
[TBL] [Abstract][Full Text] [Related]
2. Predictors of tuberculosis (TB) and antiretroviral (ARV) medication non-adherence in public primary care patients in South Africa: a cross sectional study.
Naidoo P; Peltzer K; Louw J; Matseke G; McHunu G; Tutshana B
BMC Public Health; 2013 Apr; 13():396. PubMed ID: 23622516
[TBL] [Abstract][Full Text] [Related]
3. Barriers to and enablers of uptake of and adherence to antiretroviral therapy in the context of integrated HIV and tuberculosis treatment among adults in sub-Saharan Africa: a protocol for a systematic literature review.
Momo Kadia B; Takah NF; Akem Dimala C; Smith A
BMJ Open; 2019 Oct; 9(10):e031789. PubMed ID: 31662398
[TBL] [Abstract][Full Text] [Related]
4. The impact of HIV status and antiretroviral treatment on TB treatment outcomes of new tuberculosis patients attending co-located TB and ART services in South Africa: a retrospective cohort study.
Nglazi MD; Bekker LG; Wood R; Kaplan R
BMC Infect Dis; 2015 Nov; 15():536. PubMed ID: 26584607
[TBL] [Abstract][Full Text] [Related]
5. Treatment outcomes in multidrug resistant tuberculosis-human immunodeficiency virus Co-infected patients on anti-retroviral therapy at Sizwe Tropical Disease Hospital Johannesburg, South Africa.
Umanah T; Ncayiyana J; Padanilam X; Nyasulu PS
BMC Infect Dis; 2015 Oct; 15():478. PubMed ID: 26511616
[TBL] [Abstract][Full Text] [Related]
6. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
[TBL] [Abstract][Full Text] [Related]
7. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
8. Effect of Antiretroviral Therapy on Treatment Outcomes in a Prospective Study of Extensively Drug-Resistant Tuberculosis (XDR-TB) HIV Coinfection Treatment in KwaZulu-Natal, South Africa.
Yuengling KA; Padayatchi N; Wolf A; Mathema B; Brown T; Horsburgh CR; OʼDonnell MR
J Acquir Immune Defic Syndr; 2018 Dec; 79(4):474-480. PubMed ID: 30212394
[TBL] [Abstract][Full Text] [Related]
9. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa.
Bionghi N; Daftary A; Maharaj B; Msibi Z; Amico KR; Friedland G; Orrell C; Padayatchi N; O'Donnell MR
BMC Infect Dis; 2018 Apr; 18(1):171. PubMed ID: 29642874
[TBL] [Abstract][Full Text] [Related]
10. Effect of HIV status and antiretroviral treatment on treatment outcomes of tuberculosis patients in a rural primary healthcare clinic in South Africa.
Nyasulu PS; Ngasama E; Tamuzi JL; Sigwadhi LN; Ozougwu LU; Nhandara RBC; Ayele BT; Umanah T; Ncayiyana J
PLoS One; 2022; 17(10):e0274549. PubMed ID: 36223365
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic diseases diminish the clinical benefit of immediate antiretroviral therapy in HIV-tuberculosis co-infected adults with low CD4+ cell counts.
Worodria W; Ssempijja V; Hanrahan C; Ssegonja R; Muhofwa A; Mazapkwe D; Mayanja-Kizza H; Reynolds SJ; Colebunders R; Manabe YC
AIDS; 2018 Sep; 32(15):2141-2149. PubMed ID: 30005014
[TBL] [Abstract][Full Text] [Related]
12. TB-HIV co-infection among pregnant women in Karnataka, South India: A case series.
Suresh S; Sharath BN; Anita S; Lalitha R; Prasad TJ; Rewari BB
J Infect Public Health; 2016; 9(4):465-70. PubMed ID: 26711476
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis associated mortality in a prospective cohort in Sub Saharan Africa: Association with HIV and antiretroviral therapy.
Nagu TJ; Aboud S; Mwiru R; Matee MI; Rao M; Fawzi WW; Zumla A; Maeurer MJ; Mugusi F
Int J Infect Dis; 2017 Mar; 56():39-44. PubMed ID: 28161460
[TBL] [Abstract][Full Text] [Related]
14. Survival and predictors of mortality among children co-infected with tuberculosis and human immunodeficiency virus at University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia. A retrospective follow-up study.
Atalell KA; Birhan Tebeje N; Ekubagewargies DT
PLoS One; 2018; 13(5):e0197145. PubMed ID: 29787596
[TBL] [Abstract][Full Text] [Related]
15. Bacteriologically confirmed tuberculosis in HIV-infected infants: disease spectrum and survival.
Wiseman CA; Schaaf HS; Cotton MF; Gie RP; Jennings T; Whitelaw A; Roux P; Hesseling AC
Int J Tuberc Lung Dis; 2011 Jun; 15(6):770-5. PubMed ID: 21575297
[TBL] [Abstract][Full Text] [Related]
16. A mortality review of tuberculosis and HIV co-infected patients in Mahalapye, Botswana: Does cotrimoxazole preventive therapy and/or antiretroviral therapy protect against death?
Tshitenge S; Ogunbanjo GA; Citeya A
Afr J Prim Health Care Fam Med; 2018 Nov; 10(1):e1-e5. PubMed ID: 30456967
[TBL] [Abstract][Full Text] [Related]
17. Severe adverse events during second-line tuberculosis treatment in the context of high HIV Co-infection in South Africa: a retrospective cohort study.
Schnippel K; Berhanu RH; Black A; Firnhaber C; Maitisa N; Evans D; Sinanovic E
BMC Infect Dis; 2016 Oct; 16(1):593. PubMed ID: 27769174
[TBL] [Abstract][Full Text] [Related]
18. Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
Byamungu LN; du Preez K; Walters E; Nachega JB; Schaaf HS
Int J Tuberc Lung Dis; 2018 May; 22(5):488-495. PubMed ID: 29663952
[TBL] [Abstract][Full Text] [Related]
19. Missed opportunities for accessing HIV care among Tshwane tuberculosis patients under different models of care.
Louwagie G; Girdler-Brown B; Odendaal R; Rossouw T; Johnson S; Van der Walt M
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1052-8. PubMed ID: 22691870
[TBL] [Abstract][Full Text] [Related]
20. Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America.
Caro-Vega Y; Schultze A; W Efsen AM; Post FA; Panteleev A; Skrahin A; Miro JM; Girardi E; Podlekareva DN; Lundgren JD; Sierra-Madero J; Toibaro J; Andrade-Villanueva J; Tetradov S; Fehr J; Caylà J; Losso MH; Miller RF; Mocroft A; Kirk O; Crabtree-Ramírez B
BMC Infect Dis; 2018 Apr; 18(1):191. PubMed ID: 29685113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]